Would Remsima save KRW 64.5 billion every year?
A statistics has been unveiled that medical expenses of the Crohn’s disease in U.K., Italia and France will decrease KRW 419.6 billion down for 5 years if the Celltrion’sbiosimilar‘Remsima’launches. In this statistics, the assumption was that 25% of patients using the original pharmaceutical prod...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
